martes, 18 de febrero de 2020

Weight-loss drug to be pulled from market over concerns of cancer risk

Weight-loss drug to be pulled from market over concerns of cancer risk

Cancer Briefing



Weight-loss drug to be pulled from market after FDA expresses concerns on cancer risk

By ADAM FEUERSTEIN


PATRICK SISON/AP
The FDA recommends that people using Belviq, manufactured by Japanese drug maker Eisai, should stop taking the medicine immediately.

No hay comentarios: